image

The best stocks to buy since 1993

Latest issue now available

Kape - Buys Integro for US$16m

August 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • KAPE
  • Price:
  • 130p
As was foreshadowed in my write up in April, Kape has acquired one of the two businesses it was targeting. It is using just a quarter of its US$63m cash mountain to buy Integro for US$16m, a supplier of malware protection software for Mac sold under a SaaS-based model. It comes with 150,000 paying users, with high renewal rates of above 75%. In 2017 it generated US$1.4m pretax profit - cheap looking deal.Separately in the trading statement for H1 Kape said that Adjusted EBITDA will be U$4.3m, representing growth of 48%. Adjusted EBITDA growth in the app distribution side is stated at up 172%. As a tidy up exercise, Kape has also sold its legacy low margin Media business removing an unnecessary distraction (sales of US$15m and ebitd ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe